Daniel Lim > Kirkland & Ellis International LLP > London, England > Lawyer Profile

Kirkland & Ellis International LLP Offices

Kirkland & Ellis International LLP
30 ST MARY AXE
LONDON
EC3A 8AF
England
Visit website 020 7469 2000 020 7469 2001

Daniel Lim

Daniel Lim photo
020 7469 2214 [email protected]

Work Department

Intellectual Property Litigation

Position

Daniel is a partner in Kirkland’s IP litigation team in London. Daniel has a broad practice which covers a wide range of technical fields, but is particularly noted for his experience in life science patent litigation, particularly in the pharmaceutical industry, diagnostics and the emerging fields of precision medicine and cell and gene therapy. He is also experienced in representing clients involved in complex SEP and FRAND licensing disputes.

In addition to UK litigation, Daniel is regularly called upon to assist clients in devising, coordinating and executing patent strategies for complex multijurisdictional disputes at a pan-European and global scale. With dual qualifications in law and biochemistry, and experience litigating in both Australia and Europe, Daniel is readily able to grasp highly technical material and the international dimensions of disputes which are often at the heart of effective strategies in blockbuster litigation for the most sophisticated clients. In recognition of his experience and leadership in the life sciences field, Daniel currently serves as the Vice-Chair of AIPPI’s standing committee on biotechnology.

Career

2018 to present Kirkland & Ellis International LLP; 2015-2018 Allen & Overy LLP; 2012-2015 Clayton Utz

Memberships

International Association for the Protection of Intellectual Property (AIPPI); EPLAW – European Patent Lawyers Association

Education

University of Oxford (Postgraduate Diploma in Intellectual Property Law and Practice, 2016); The University of Sydney (LL.B., 2011); The University of Sydney (B.Sc., 2009)

Lawyer Rankings

London > Industry focus > Life sciences and healthcare

Described as ‘one of the best teams in life sciences and healthcare in London’ Kirkland & Ellis International LLP advises a multitude of major life sciences companies on the global formulation and coordination of life science patent litigation strategy. Daniel Lim co-heads the practice and has a proven track record in pharmaceutical and medical device litigation. Fellow co-head Nicola Dagg is a known name for work including strategic patent and product lifecycle advice. Emma Flett completes the leadership team and is geared to advise on the of IP aspects of M&A transactions. SPC disputes relating to biologic and small molecule products are a practice strength of Steven Baldwin, while Jin Ooi works extensively on follow-on damages inquiry mandates.

London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)

Praised for its ‘unbeatable combination of experience, talent and tenacity’, Kirkland & Ellis International LLP operates for a consortium of notable clients in multi-faceted mandates that tackle complex issues such as SEP/FRAND and technically challenging M&A. Nicola Dagg helms the litigation side of the practice with her market traction in the most cutting-edge mandates, while Emma Flett, who leads the technology and transactional side of the practice, demonstrates a strong grounding in a litany of mandates, from private equity transactions and M&A to licensing and development issues. Daniel Lim is well positioned to represent clients in litigation that involves medical devices, SEP/FRAND, and blockbusters in the life sciences space. Steven Baldwin is notably active in the High Court, representing clients in relation to high-tech and life sciences issues. Another name to note is experienced litigator Jin Ooi, who is pre-eminent in the fields of life sciences and consumer products. Katie Coltart departed to Linklaters LLP in September 2023.

Lawyer Rankings

Top Tier Firm Rankings

Firm Rankings